Skip to main content
. 2010 Aug 24;103(6):827–836. doi: 10.1038/sj.bjc.6605832

Figure 5.

Figure 5

Immunofluorescence analysis of apoptosis and proliferation in subcutaneous glioblastoma xenografts, 24 h after the third injection of therapeutic agents. Results show a clear increase in apoptosis and the complete suppression of proliferation in the combination F16–IL2+temozolomide treatment group. Scale bars indicate 50 μm.